In our RCC cell lines, we demonstrated that CD40 engagement by CD40 ligand was able to significantly increase the transcription of different members of the NFAT family, in particular NFATc2, NFATc3 and NFATc4. This evidence concerns the gene CD40 and renal cell carcinoma.